Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Solubility of volatile anesthetics in plasma substitutes, albumin, intravenous fat emulsions, perfluorochemical emulsion, and aqueous solutions.

Journal of anesthesia

Shim JC, Kaminoh Y, Tashiro C, Miyamoto Y, Yoo HK.
PMID: 28921091
J Anesth. 1996 Dec;10(4):276-281. doi: 10.1007/BF02483395.

Using the gas chromatographic headspace sampling technique, we determined the solubility of volatile anesthetics (halothane, enflurane, isoflurane, and sevoflurane) in plasma substitutes, albumin solution, intravenous fat emulsions, perfluorochemical FC-43 emulsion, and aqueous solutions at 37°C. The order of magnitude...

Cite
Shim JC, Kaminoh Y, Tashiro C, et al. Solubility of volatile anesthetics in plasma substitutes, albumin, intravenous fat emulsions, perfluorochemical emulsion, and aqueous solutions. J Anesth. 1996;10(4):276-281doi: 10.1007/BF02483395.
Shim, J. C., Kaminoh, Y., Tashiro, C., Miyamoto, Y., & Yoo, H. K. (1996). Solubility of volatile anesthetics in plasma substitutes, albumin, intravenous fat emulsions, perfluorochemical emulsion, and aqueous solutions. Journal of anesthesia, 10(4), 276-281. https://doi.org/10.1007/BF02483395
Shim, Jaes Chol, et al. "Solubility of volatile anesthetics in plasma substitutes, albumin, intravenous fat emulsions, perfluorochemical emulsion, and aqueous solutions." Journal of anesthesia vol. 10,4 (1996): 276-281. doi: https://doi.org/10.1007/BF02483395
Shim JC, Kaminoh Y, Tashiro C, Miyamoto Y, Yoo HK. Solubility of volatile anesthetics in plasma substitutes, albumin, intravenous fat emulsions, perfluorochemical emulsion, and aqueous solutions. J Anesth. 1996 Dec;10(4):276-281. doi: 10.1007/BF02483395. PMID: 28921091.
Copy Download .nbib Format: NLM
PLASMA SUBSTITUTES : HUMAN AND ANIMAL GLOBIN RELATED TO THE PRODUCTION OF HEMOGLOBIN AND PLASMA PROTEIN DOG HEMOGLOBIN UTILIZATION IMPROVED BY METHIONINE BUT NOT BY ISOLEUCINE.

The Journal of experimental medicine

Robscheit-Robbins FS, Miller LL, Alling EL, Whipple GH.
PMID: 19871535
J Exp Med. 1946 Apr 30;83(5):355-71.

Hemoglobin and globin alone, supplemented, or modified in various ways are seriously considered as plasma substitutes. Human globin given to doubly depleted (anemic and hypoproteinemic) dogs by vein contributes to the production of new hemoglobin and plasma protein, but...

Cite
Robscheit-Robbins FS, Miller LL, Alling EL, et al. PLASMA SUBSTITUTES : HUMAN AND ANIMAL GLOBIN RELATED TO THE PRODUCTION OF HEMOGLOBIN AND PLASMA PROTEIN DOG HEMOGLOBIN UTILIZATION IMPROVED BY METHIONINE BUT NOT BY ISOLEUCINE. J Exp Med. 1946;83(5):355-71
Robscheit-Robbins, F. S., Miller, L. L., Alling, E. L., & Whipple, G. H. (1946). PLASMA SUBSTITUTES : HUMAN AND ANIMAL GLOBIN RELATED TO THE PRODUCTION OF HEMOGLOBIN AND PLASMA PROTEIN DOG HEMOGLOBIN UTILIZATION IMPROVED BY METHIONINE BUT NOT BY ISOLEUCINE. The Journal of experimental medicine, 83(5), 355-71.
Robscheit-Robbins, F S, et al. "PLASMA SUBSTITUTES : HUMAN AND ANIMAL GLOBIN RELATED TO THE PRODUCTION OF HEMOGLOBIN AND PLASMA PROTEIN DOG HEMOGLOBIN UTILIZATION IMPROVED BY METHIONINE BUT NOT BY ISOLEUCINE." The Journal of experimental medicine vol. 83,5 (1946): 355-71.
Robscheit-Robbins FS, Miller LL, Alling EL, Whipple GH. PLASMA SUBSTITUTES : HUMAN AND ANIMAL GLOBIN RELATED TO THE PRODUCTION OF HEMOGLOBIN AND PLASMA PROTEIN DOG HEMOGLOBIN UTILIZATION IMPROVED BY METHIONINE BUT NOT BY ISOLEUCINE. J Exp Med. 1946 Apr 30;83(5):355-71. PMID: 19871535; PMCID: PMC2135595.
Copy Download .nbib Format: NLM
Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review.

Perioperative medicine (London, England)

Odor PM, Bampoe S, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, Grocott MPW, James MFM, Mythen MG, O'Malley CMN, Roche AM, Rowan K, Burdett E.
PMID: 30559961
Perioper Med (Lond). 2018 Dec 13;7:27. doi: 10.1186/s13741-018-0108-5. eCollection 2018.

BACKGROUND: Buffered intravenous fluid preparations contain substrates to maintain acid-base status. The objective of this systematic review was to compare the effects of buffered and non-buffered fluids administered during the perioperative period on clinical and biochemical outcomes.METHODS: We searched...

Cite
Odor PM, Bampoe S, Dushianthan A, et al. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review. Perioper Med (Lond). 2018;7:27doi: 10.1186/s13741-018-0108-5.
Odor, P. M., Bampoe, S., Dushianthan, A., Bennett-Guerrero, E., Cro, S., Gan, T. J., Grocott, M. P. W., James, M. F. M., Mythen, M. G., O'Malley, C. M. N., Roche, A. M., Rowan, K., & Burdett, E. (2018). Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review. Perioperative medicine (London, England), 727. https://doi.org/10.1186/s13741-018-0108-5
Odor, Peter M, et al. "Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review." Perioperative medicine (London, England) vol. 7 (2018): 27. doi: https://doi.org/10.1186/s13741-018-0108-5
Odor PM, Bampoe S, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, Grocott MPW, James MFM, Mythen MG, O'Malley CMN, Roche AM, Rowan K, Burdett E. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review. Perioper Med (Lond). 2018 Dec 13;7:27. doi: 10.1186/s13741-018-0108-5. eCollection 2018. PMID: 30559961; PMCID: PMC6291967.
Copy Download .nbib Format: NLM
Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568.

British journal of anaesthesia

Wiedermann CJ, Wiedermann W.
PMID: 34756459
Br J Anaesth. 2022 Jan;128(1):e4-e6. doi: 10.1016/j.bja.2021.09.021. Epub 2021 Oct 28.

No abstract available.

Cite
Wiedermann CJ, Wiedermann W. Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568. Br J Anaesth. 2021;128(1):e4-e6doi: 10.1016/j.bja.2021.09.021.
Wiedermann, C. J., & Wiedermann, W. (2022). Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568. British journal of anaesthesia, 128(1), e4-e6. https://doi.org/10.1016/j.bja.2021.09.021
Wiedermann, Christian J, and Wiedermann, Wolfgang. "Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568." British journal of anaesthesia vol. 128,1 (2022): e4-e6. doi: https://doi.org/10.1016/j.bja.2021.09.021
Wiedermann CJ, Wiedermann W. Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568. Br J Anaesth. 2022 Jan;128(1):e4-e6. doi: 10.1016/j.bja.2021.09.021. Epub 2021 Oct 28. PMID: 34756459.
Copy Download .nbib Format: NLM
Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568.

British journal of anaesthesia

Wiedermann CJ, Wiedermann W.
PMID: 34756459
Br J Anaesth. 2021 Oct 27; doi: 10.1016/j.bja.2021.09.021. Epub 2021 Oct 27.

No abstract available.

Cite
Wiedermann CJ, Wiedermann W. Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568. Br J Anaesth. 2021;doi: 10.1016/j.bja.2021.09.021.
Wiedermann, C. J., & Wiedermann, W. (2021). Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568. British journal of anaesthesia, . https://doi.org/10.1016/j.bja.2021.09.021
Wiedermann, Christian J, and Wiedermann, Wolfgang. "Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568." British journal of anaesthesia vol. (2021). doi: https://doi.org/10.1016/j.bja.2021.09.021
Wiedermann CJ, Wiedermann W. Safety of tetrastarch in surgical patients: a meta-analysis revisited. Comment on Br J Anaesth 2021; 127: 556-568. Br J Anaesth. 2021 Oct 27; doi: 10.1016/j.bja.2021.09.021. Epub 2021 Oct 27. PMID: 34756459.
Copy Download .nbib Format: NLM
Cost-effectiveness of Chloride-liberal versus Chloriderestrictive Intravenous Fluids among Patients Hospitalized in the United States.

Journal of health economics and outcomes research

Perrault L, Makhija D, Beer I, Laplante S, Iannazzo S, Raghunathan K.
PMID: 34414248
J Health Econ Outcomes Res. 2016 Apr 07;4(1):90-102. doi: 10.36469/9829. eCollection 2016.

No abstract available.

Cite
Perrault L, Makhija D, Beer I, et al. Cost-effectiveness of Chloride-liberal versus Chloriderestrictive Intravenous Fluids among Patients Hospitalized in the United States. J Health Econ Outcomes Res. 2016;4(1):90-102doi: 10.36469/9829.
Perrault, L., Makhija, D., Beer, I., Laplante, S., Iannazzo, S., & Raghunathan, K. (2016). Cost-effectiveness of Chloride-liberal versus Chloriderestrictive Intravenous Fluids among Patients Hospitalized in the United States. Journal of health economics and outcomes research, 4(1), 90-102. https://doi.org/10.36469/9829
Perrault, Louise, et al. "Cost-effectiveness of Chloride-liberal versus Chloriderestrictive Intravenous Fluids among Patients Hospitalized in the United States." Journal of health economics and outcomes research vol. 4,1 (2016): 90-102. doi: https://doi.org/10.36469/9829
Perrault L, Makhija D, Beer I, Laplante S, Iannazzo S, Raghunathan K. Cost-effectiveness of Chloride-liberal versus Chloriderestrictive Intravenous Fluids among Patients Hospitalized in the United States. J Health Econ Outcomes Res. 2016 Apr 07;4(1):90-102. doi: 10.36469/9829. eCollection 2016. PMID: 34414248; PMCID: PMC8341618.
Copy Download .nbib Format: NLM
GELATIN-ITS USEFULNESS AND TOXICITY : BLOOD PROTEIN PRODUCTION IMPAIRED BY CONTINUED GELATIN BY VEIN.

The Journal of experimental medicine

Robscheit-Robbins FS, Miller LL, Whipple GH.
PMID: 19871403
J Exp Med. 1944 Aug 01;80(2):145-64. doi: 10.1084/jem.80.2.145.

Gelatin given by vein to doubly depleted dogs (anemic and hypoproteinemic) gives no immediate toxic response, no anaphylactoid reactions, and may contribute something to the building of new hemoglobin and plasma protein. Gelatin given by vein during 1 to...

Cite
Robscheit-Robbins FS, Miller LL, Whipple GH. GELATIN-ITS USEFULNESS AND TOXICITY : BLOOD PROTEIN PRODUCTION IMPAIRED BY CONTINUED GELATIN BY VEIN. J Exp Med. 1944;80(2):145-64doi: 10.1084/jem.80.2.145.
Robscheit-Robbins, F. S., Miller, L. L., & Whipple, G. H. (1944). GELATIN-ITS USEFULNESS AND TOXICITY : BLOOD PROTEIN PRODUCTION IMPAIRED BY CONTINUED GELATIN BY VEIN. The Journal of experimental medicine, 80(2), 145-64. https://doi.org/10.1084/jem.80.2.145
Robscheit-Robbins, F S, et al. "GELATIN-ITS USEFULNESS AND TOXICITY : BLOOD PROTEIN PRODUCTION IMPAIRED BY CONTINUED GELATIN BY VEIN." The Journal of experimental medicine vol. 80,2 (1944): 145-64. doi: https://doi.org/10.1084/jem.80.2.145
Robscheit-Robbins FS, Miller LL, Whipple GH. GELATIN-ITS USEFULNESS AND TOXICITY : BLOOD PROTEIN PRODUCTION IMPAIRED BY CONTINUED GELATIN BY VEIN. J Exp Med. 1944 Aug 01;80(2):145-64. doi: 10.1084/jem.80.2.145. PMID: 19871403; PMCID: PMC2135456.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries